101 related articles for article (PubMed ID: 8425763)
1. Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer.
Baxevanis CN; Reclos GJ; Papamichail M
Int J Cancer; 1993 Jan; 53(2):264-8. PubMed ID: 8425763
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
[TBL] [Abstract][Full Text] [Related]
3. The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by Prothymosin-alpha.
Cordero OJ; Sarandeses C; López-Rodríguez JL; Nogueira M
Immunopharmacology; 1995 Apr; 29(3):215-23. PubMed ID: 7542644
[TBL] [Abstract][Full Text] [Related]
4. Prothymosin alpha restores the depressed autologous and allogeneic mixed lymphocyte responses in patients with systemic lupus erythematosus.
Baxevanis CN; Reclos GJ; Papamichail M; Tsokos GC
Immunopharmacol Immunotoxicol; 1987; 9(4):429-40. PubMed ID: 2963855
[TBL] [Abstract][Full Text] [Related]
5. Prothymosin alpha enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity.
Cordero OJ; Sarandeses CS; López JL; Nogueira M
Lymphokine Cytokine Res; 1992 Oct; 11(5):277-85. PubMed ID: 1467368
[TBL] [Abstract][Full Text] [Related]
6. Induction of lymphokine-activated killer activity in mice by prothymosin alpha.
Baxevanis CN; Gritzapis AD; Dedoussis GV; Papadopoulos NG; Tsolas O; Papamichail M
Cancer Immunol Immunother; 1994 Apr; 38(4):281-6. PubMed ID: 8168124
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.
Eckert K; Grünberg E; Immenschuh P; Garbin F; Kreuser ED; Maurer HR
J Cancer Res Clin Oncol; 1997; 123(8):420-8. PubMed ID: 9292704
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin alpha.
López-Rodríguez JL; Cordero OJ; Sarandeses C; Viñuela J; Nogueira M
Lymphokine Cytokine Res; 1994 Jun; 13(3):175-82. PubMed ID: 7948426
[TBL] [Abstract][Full Text] [Related]
9. Prothymosin alpha 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients.
Garbin F; Eckert K; Immenschuh P; Kreuser ED; Maurer HR
Int J Immunopharmacol; 1997 Jun; 19(6):323-32. PubMed ID: 9467751
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte response.
Baxevanis CN; Reclos GJ; Economou M; Arsenis P; Katsiyiannis A; Seferiades K; Papadopoulos G; Tsolas O; Papamichail M
Immunopharmacol Immunotoxicol; 1988; 10(4):443-61. PubMed ID: 2977606
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis.
Reclos GJ; Baxevanis CN; Sfagos C; Papageorgiou C; Tsokos GC; Papamichail M
Clin Exp Immunol; 1987 Nov; 70(2):336-44. PubMed ID: 2962790
[TBL] [Abstract][Full Text] [Related]
12. Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha.
Baxevanis CN; Gritzapis AD; Spanakos G; Tsitsilonis OE; Papamichail M
Cancer Immunol Immunother; 1995 Jun; 40(6):410-8. PubMed ID: 7543022
[TBL] [Abstract][Full Text] [Related]
13. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
[TBL] [Abstract][Full Text] [Related]
14. Prothymosin alpha 1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro.
Eckert K; Garbin F; Maurer HR; Büttner P; Garbe C; Czarnecki J
Int J Immunopharmacol; 1995 Jul; 17(7):555-61. PubMed ID: 8586483
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients.
Eckert K; Grünberg E; Garbin F; Maurer HR
Int J Immunopharmacol; 1997; 19(9-10):493-500. PubMed ID: 9637344
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human T lymphocyte functions by prothymosin alpha. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses.
Baxevanis CN; Reclos GJ; Panneerselvam C; Papamichail M
Immunopharmacology; 1988; 15(2):73-84. PubMed ID: 2967267
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes.
Baxevanis CN; Frillingos S; Seferiadis K; Reclos GJ; Arsenis P; Katsiyiannis A; Anastasopoulos E; Tsolas O; Papamichail M
Immunopharmacol Immunotoxicol; 1990; 12(4):595-617. PubMed ID: 2092041
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.
Serrate SA; Schulof RS; Leondaridis L; Goldstein AL; Sztein MB
J Immunol; 1987 Oct; 139(7):2338-43. PubMed ID: 3116079
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
Parhar RS; Lala PK
J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture.
Callewaert DM; Lightbody JJ; Kaplan J; Jaroszewski J; Peterson WD; Rosenberg JC
J Immunol; 1978 Jul; 121(1):81-5. PubMed ID: 149818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
